Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats.

about

Neuroprotection as a Therapeutic Target for Diabetic Retinopathy Mechanism study of isoflavones as an anti-retinoblastoma progression agent.

P2860

Q26749178-4DF3E0AA-31B5-42D2-8BF0-A13A21045486 Q45928122-21421936-114E-4DA3-B426-C72DDB29A31B

P2860

Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats.

Item

http://www.wikidata.org/entity/Q52903973

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Genistein Treatment Confers Pr ...... f the Diabetic Retina in Rats.

@en

Genistein Treatment Confers Pr ...... f the Diabetic Retina in Rats.

@nl

type

Item

label

Genistein Treatment Confers Pr ...... f the Diabetic Retina in Rats.

@en

Genistein Treatment Confers Pr ...... f the Diabetic Retina in Rats.

@nl

prefLabel

Genistein Treatment Confers Pr ...... f the Diabetic Retina in Rats.

@en

Genistein Treatment Confers Pr ...... f the Diabetic Retina in Rats.

@nl

P1476

Genistein Treatment Confers Pr ...... f the Diabetic Retina in Rats.

@en

P2093

Abdelrahman A Sayed

http://www.w3.org/2001/XMLSchema#string

Maha M Abdel-Rouf

http://www.w3.org/2001/XMLSchema#string

Sanaa A M Elgayar

http://www.w3.org/2001/XMLSchema#string

P2860

Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro

Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy

Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.

The role of microglia in diabetic retinopathy

Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: a three-dimensional confocal morphometric and proteomic study.

High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes

Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications.

Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.

Pathogenetic mechanisms of diabetic nephropathy.

Targets of tyrosine nitration in diabetic rat retina.

P304

385-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/01913123.2015.1045664

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sohair A Eltony

P577

2015-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281035873

http://www.w3.org/2001/XMLSchema#string

P698

26548435

http://www.w3.org/2001/XMLSchema#string

Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats.

about

P2860

P2860

Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698